Polish biotechnology companies join forces to compete in global market

Covid-19 pandemic has contributed significantly to the rise in popularity of biotechnology, as has all health-related industries. In Poland, this sector has been gaining importance for several years and has found itself at the center of government strategies, as evidenced by, inter alia, the appointment of a government plenipotentiary for biotechnology or the acquisition of shares in Mabion and Selvita by the Polish Development Fund.